Palisade Bio (PALI) said Wednesday it priced an upsized underwritten public offering of about 171.4 million shares priced at $0.70 per share to raise gross proceeds of $120 million.
Underwriters were given a 45-day option to buy up to an additional about 25.7 million shares, the company said.
The offering is expected to close on or about Thursday, Palisade Bio said.
The company's shares were up 17% in recent trading.
Price: 1.00, Change: +0.14, Percent Change: +16.23
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments